The case for & against
Bull & Bear analysis
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a leading provider of behavioral health services in the United States, particularly focused on treating individuals with mental health issues and substance use disorders. With over 275 facilities, Acadia serves more than 84,000 patients daily. As a dominant player in the rapidly growing mental health care sector, Acadia operates within the context of increasing awareness and demand for behavioral health services, particularly against the backdrop of a national mental health crisis.
Bull says
- ↑Plans to add 400–600 beds in 2026 after adding 2,500+ beds
- ↑Q1 2026 revenue of $828.8M (+7.6% YoY) and adjusted EBITDA of $144.2M
- ↑Same-facility revenue growth of 7.3% YoY and patient occupancy +6.2%
- ↑20% jump in acute service inquiries underscores strong demand
- ↑High institutional ownership and positive analyst revisions indicate confidence
- ↑Robust Book-to-Price valuation suggests attractive upside potential
Bear says
- ↓6.5% revenue decline in specialty facilities in Pennsylvania
- ↓Ongoing Medicaid and payer denials erode adjusted EBITDA guidance
- ↓Expecting $15M in quarterly startup losses for new facilities
- ↓Leverage ratio of 0.56x raises debt servicing and liquidity risks
- ↓Weak profitability factors and negative earnings yield signal caution
- ↓High short interest and low growth outlook reflect market skepticism
Investment themes with ACHC
Earnings Call · Q1 2026 · Mgmt. Guidance
Transcript signals
Bull points
- our inquiries for acute were up over 20%
- Demand is huge, continuing to be strong, and there are individuals that are seeking care, and we have not seen that reduced. We've actually seen it strengthened, and that's contributed to some of our results in the admission area.
- And we actually saw some very strong performance at some of our specialty programs that pull patients from around the country. Our commercial payer mix is up, and I think that team is doing very well.
Bear points
- startup losses are still tracking around $15 million per quarter.
- On the CTC side of the business, while we grew 2.5% compared to the first quarter of 2025, growth slowed sequentially from quarter four, as that business was impacted by the severe weather we noted on our February call, as certain centers had to be closed during that time.
- The decline in our specialty facility revenue of 6.5% was driven by the previously discussed challenges in Pennsylvania and from closing specialty facilities in 2025. The closures created nearly a 6% headwind to growth.